Web Results

www.lexisnexis.com/legalnewsroom/litigation/b/litigation-blog/archive/2014/04/08/jury-awards-9b-in-1st-mdl-actos-bladder-cancer-trial-against-takeda-eli-lilly.aspx

Apr 8, 2014 ... Inc., according to Takeda (In Re: Actos [Pioglitazone] Products Liability Litigation, MDL Docket No. 2299, No. 6:11-md-2299, Allen v. Takeda Pharmaceuticals North America Inc., et al., No. 12-64, E.D. La.). According to an April 8 press release issued by Takeda, the nine-member jury in the U.S. District ...

caselaw.findlaw.com/us-federal-circuit/1657936.html

Feb 20, 2014 ... Case opinion for US Federal Circuit TAKEDA PHARMACEUTICAL COMPANY LIMITED LLC v. ZYDUS PHARMACEUTICALS USA INC. Read the Court's full decision on FindLaw.

mdcourts.gov/cosappeals/pdfs/201411schedule.pdf

Nov 3, 2014 ... 02112/13 Camhong An et al. vs. Takeda Pharmaceuticals America,. Inc. et al. No. 01768/13 Canopius US Insurance, Inc. f/k/a Omega US Insurance, Inc. vs. RN'G Construction, Inc. et al. No. 02208/13 Albert Lee Jones, IV vs. State of Maryland. Courtroom No. 2. No. 02175/13 100 Harborview Drive Council ...

www.mintz.com/professionals/detail/name/thomas-h-wintner

Mylan Pharmaceuticals, Inc. v. Nissan Chemical Industries, Ltd., IPR2015-01069, Paper No. 24 (PTAB Oct. 20, 2015): On behalf of pharmaceutical company patent owner, obtained decision denying institution of IPR. Sawai USA, Inc. et al. v. Nissan Chemical Industries, Ltd., IPR2015-01647, Paper No. 9 (PTAB Feb.